Please login to the form below

Not currently logged in
Email:
Password:

Advent International

This page shows the latest Advent International news and features for those working in and with pharma, biotech and healthcare.

Private equity firms agree deal to take over Stada

Private equity firms agree deal to take over Stada

Private equity firms agree deal to take over Stada. Cinven and Bain Capital beat out competition from Advent International. ... Cinven and Bain Capital made what Stada said was the "most financially appealing offer" of 66 per share, topping an earlier

Latest news

  • Stada opens books to let formal bidding commence Stada opens books to let formal bidding commence

    Stada opens books to let formal bidding commence. Cinven, Advent International and Bain Capital now have opportunity to revise their bids. ... The three interested parties - confirmed as Cinven, Advent International and Bain Capital - will now all

  • Advent tops Cinven offer for Stada as third suitor looms Advent tops Cinven offer for Stada as third suitor looms

    Private equity firm Advent International has topped an earlier bid from rival Cinven for Stada and matched an offer from an undisclosed third party. ... needs to develop a new culture in order to succeed on the international stage.

  • UCB to sell its US generics business for $1.5bn UCB to sell its US generics business for $1.5bn

    UCB to sell its US generics business for $1.5bn. Advent International and Avista Capital Partners will take control of Kremers Urban Pharmaceuticals. ... The buyers are Advent International and Avista Capital Partners, both private equity firms with a

  • GSK plans to sell off older products GSK plans to sell off older products

    conference. Among the firms given the opportunity to view the portfolio are Advent International, Blackstone and KKR, according to Reuters, which indicated the overture was initially revealed by Sky News.

  • Chiesi launches Flogoprofen website Chiesi launches Flogoprofen website

    The company has also since acquired Laboratorios Dreiman Chiesi and Advent International, and has more than 200 employees in Spain today.

More from news
Approximately 2 fully matching, plus 5 partially matching documents found.

Latest Intelligence

  • Deal Watch February 2017 Deal Watch February 2017

    Earlier in the month the private equity (PE) firm Cinven offered 56 a share to acquire Stada but this has been topped by a binding offer from another PE company, Advent ... International Corporation, for 58 a share valuing the company at 3.6bn ($3.8bn).

  • Deal Watch table for November 2014 Deal Watch table for November 2014

    UCB (Kremers Urban Pharma) /Advent International and Avista Capital Partners. Generics portfolio.

  • Pharma deals during November 2014 Pharma deals during November 2014

    Similarly UCB is understood to be selling its highly profitable generics business Kremers Urban Pharmaceuticals to Advent International and Avista Capital Partners for $1.53bn to allow it to focus on ... Bridget brings to the Medius Associates team her

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • 101translations

    101translations. With the advent of the internet, international communication has become the norm, with people reaching out globally.

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Publicis Resolute

Publicis Life Brands Resolute provides real-life practical solutions to your issues, without fuss or fluff. We are an experienced team...

Latest intelligence

Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe’s leading hub for life sciences innovation...
Ali Frederic Ben-Amor
Tackling a formidable foe
Ali Frederic Ben-Amor tells how Merck is taking the fight to multiple sclerosis...

Infographics